Windlas Biotech's Stock Reaches 52-Week High, Outperforms Sector with Impressive 9.71% Gain
Windlas Biotech, a smallcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high of Rs. 1197 on November 6, 2024. The stock has gained 9.71% in the last two days and is outperforming the sector by 7.48%. Its moving averages and 1-year performance also indicate a positive trend.
Windlas Biotech, a smallcap pharmaceutical company, has been making waves in the stock market as its share price reached a 52-week high on November 6, 2024. The company's stock has been on an upward trend, gaining 9.71% in the last two days and outperforming the sector by 7.48%.
On November 6, the stock hit an all-time high of Rs. 1197, which is a significant increase from its previous closing price. The stock has also been highly volatile, with an intraday volatility of 7.21%, calculated from the weighted average price.
Windlas Biotech's strong performance can also be seen in its moving averages, as it is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock.
In comparison to the Sensex's performance of 23.48%, Windlas Biotech has shown an impressive 1-year performance of 214.55%. This further solidifies the company's position as a strong player in the pharmaceutical industry.
While there has been no mention of investor interest or expert opinions, MarketsMOJO has given a 'Hold' call for Windlas Biotech's stock. With its recent success and strong performance, Windlas Biotech is definitely a company to watch out for in the smallcap pharmaceutical sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
